BioLife Solutions, Inc. Increase (Decrease) in Equity Securities, FV-NI
BioLife Solutions, Inc. (BLFS) reported Increase (Decrease) in Equity Securities, FV-NI of $983.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi · last filed 2026-02-26
- BioLife Solutions, Inc. increase (decrease) in equity securities, fv-ni for the quarter ending 2025-12-31 was $942.00K.
- BioLife Solutions, Inc. increase (decrease) in equity securities, fv-ni for the quarter ending 2025-09-30 was $41.00K.
- BioLife Solutions, Inc. increase (decrease) in equity securities, fv-ni for the quarter ending 2024-12-31 was $0.00.
- BioLife Solutions, Inc. increase (decrease) in equity securities, fv-ni for the quarter ending 2024-09-30 was $0.00.
- BioLife Solutions, Inc. increase (decrease) in equity securities, fv-ni for fiscal 2025 was $983.00K.
- BioLife Solutions, Inc. increase (decrease) in equity securities, fv-ni for fiscal 2024 was -$4.07M.
- BioLife Solutions, Inc. increase (decrease) in equity securities, fv-ni for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- BioLife Solutions, Inc. increase (decrease) in equity securities, fv-ni for fiscal 2022 was $697.00K.
| Period end | Increase (Decrease) in Equity Securities, FV-NI 3 month | Increase (Decrease) in Equity Securities, FV-NI 6 month | Increase (Decrease) in Equity Securities, FV-NI 9 month | Increase (Decrease) in Equity Securities, FV-NI 12 month |
|---|---|---|---|---|
| 2025-12-31 | $942.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $983.00K derived: sum of 2 quarters · filed 2026-02-26 | $983.00K 10-K · filed 2026-02-26 | |
| 2025-09-30 | $41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $41.00K 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | -$4.07M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$4.07M 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | -$4.07M 10-Q · filed 2025-08-07 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-09 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $697.00K 10-K · filed 2025-03-03 | ||
| 2022-09-30 | $697.00K 10-Q · filed 2023-11-09 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |